BeStock  
Stocks › Biotechnology › CGEM

Cullinan Therapeutics CGEM

US equityMarket cap rank #3236Biotechnology
$15.63 −$0.62 (-3.82%)
Pre-market · Oct 8, 8:20 am ET · After hours $15.63 0.00%
Open$15.95
Prev close$16.25
Day range$15.47 – $16.46
Volume808.2K
Market cap$1.01B
P/E (TTM)–
Dividend yield–

CGEM Stock News

Headlines matching Cullinan Therapeutics or the CGEM ticker, most recent first.

  • H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $35 PositiveMarket news · 26 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Cullinan Therapeutics(CGEM.US), With a Forecast Between $33 to $40Market news · 25 Sep 2026 · Direct mention
  • Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $42 PositiveMarket news · 16 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Cullinan Therapeutics(CGEM.US), With a Forecast Between $30 to $42Market news · 15 Sep 2026 · Direct mention
  • JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36Market news · 14 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30Market news · 17 Aug 2026 · Direct mention
  • UBS Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $27 PositiveMarket news · 17 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30Market news · 17 Aug 2026 · Direct mention
  • Clear Street Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $47Market news · 15 Aug 2026 · Direct mention
  • Stifel Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28Market news · 14 Aug 2026 · Direct mention
  • Clear Street Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $47 PositiveMarket news · 13 Aug 2026 · Direct mention
  • BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $39Market news · 29 Jul 2026 · Direct mention
  • BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $39 PositiveMarket news · 29 Jul 2026 · Direct mention
  • Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $37Market news · 29 Jul 2026 · Direct mention
  • Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $42Market news · 7 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on CGEM.

Leave a comment

Scroll to Top